[ibd-display-video id=2102289 width=50 float=left autostart=true] IBD's unique rating tracks price action with a 1 (worst) to 99 (best) score. The rating shows how a stock's price behavior over the trailing 52 weeks compares to all the other stocks in our database.
Decades of market research shows that the stocks that go on to make the biggest gains typically have an 80 or better RS Rating as they begin their largest climbs. See if Humana can continue to show renewed price strength and clear that threshold.
Humana is still within a buying range after clearing a 262.60 entry in a cup with handle . Once a stock moves 5% or higher beyond the original entry, it's considered out of buy range.
Humana posted 6% EPS growth in the latest quarterly report. Sales increased -3%. Keep an eye out for the company's next round of numbers on or around Feb. 8.
Humana earns the No. 10 rank among its peers in the Medical-Managed Care industry group. Centene ( CNC ), Wellcare Health Plans ( WCG ) and UnitedHealth ( UNH ) are among the top 5 highly rated stocks within the group.